|
Volumn 31, Issue 1-2, 1999, Pages 629-632
|
Induction of islet transplantation tolerance using donor specific transfusion and anti-CD154 monoclonal antibody
a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CD40 LIGAND MONOCLONAL ANTIBODY;
MONOCLONAL ANTIBODY;
UNCLASSIFIED DRUG;
ANTIGEN PRESENTATION;
AUTOIMMUNITY;
CLINICAL PROTOCOL;
CONFERENCE PAPER;
DIABETES MELLITUS;
GRAFT REJECTION;
GRAFT SURVIVAL;
IMMUNOLOGICAL TOLERANCE;
IMMUNOMODULATION;
IMMUNOSUPPRESSIVE TREATMENT;
PANCREAS ISLET TRANSPLANTATION;
PATHOPHYSIOLOGY;
POSTOPERATIVE COMPLICATION;
PRIORITY JOURNAL;
RECURRENT DISEASE;
SPLEEN CELL;
SURVIVAL RATE;
T LYMPHOCYTE ACTIVATION;
THYMUS;
ANIMALS;
ANTIBODIES, MONOCLONAL;
BLOOD TRANSFUSION;
CD40 LIGAND;
DIABETES MELLITUS, TYPE 1;
GRAFT REJECTION;
HUMANS;
IMMUNOSUPPRESSION;
ISLETS OF LANGERHANS TRANSPLANTATION;
LYMPHOCYTE TRANSFUSION;
MEMBRANE GLYCOPROTEINS;
T-LYMPHOCYTES;
|
EID: 0033062447
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(98)01589-9 Document Type: Conference Paper |
Times cited : (22)
|
References (15)
|